Future therapeutic perspectives for tension-type headache
- 5 December 2007
- journal article
- review article
- Published by Springer Nature in Current Pain and Headache Reports
- Vol. 11 (6) , 461-464
Abstract
The therapy for tension-type headache remains insufficient, and recent advances have been scarce. Although tricyclic antidepressants are at the forefront of treatment advances, upcoming agents tentatively modifying central sensitization are promising. Botulinum toxin failed to meet expectations. This article reviews current treatments, emphasizing newer approaches. Much remains to be achieved.Keywords
This publication has 45 references indexed in Scilit:
- Aspirin and tension-type headacheThe Journal of Headache and Pain, 2007
- Long-term benefits of botulinum toxin type A (BOTOX) in chronic daily headache: a five-year long experienceThe Journal of Headache and Pain, 2006
- A Comparison of Selected Osteopathic Treatment and Relaxation for Tension‐Type HeadachesHeadache: The Journal of Head and Face Pain, 2006
- Efficacy of Physiotherapy Including a Craniocervical Training Programme for Tension-Type Headache; A Randomized Clinical TrialCephalalgia, 2006
- Combination of tizanidine and amitriptyline in the prophylaxis of chronic tension–type headache: evaluation of efficacy and impact on quality of lifeThe Journal of Headache and Pain, 2005
- New developments in the pharmacotherapy of tension-type headachesExpert Opinion on Pharmacotherapy, 2003
- Sertraline versus amitriptyline in the prophylactic therapy of non-depressed chronic tension-type headache patientsThe Journal of Headache and Pain, 2003
- Tension headaches and muscle tension: is there a role for magnesium?Medical Hypotheses, 2001
- Sumatriptan has no clinically relevant effect in the treatment of episodic tension‐type headacheEuropean Journal of Neurology, 1996
- Efficacy and Tolerability of Amitriptylinoxide in the Treatment of Chronic Tension-Type Headache: A Multi-Centre Controlled StudyCephalalgia, 1994